Christopher Sullivan
Director Financiero/CFO en AVALO THERAPEUTICS, INC. .
Fortuna: 75 $ al 30/04/2024
Cargos activos de Christopher Sullivan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AVALO THERAPEUTICS, INC. | Director Financiero/CFO | 14/02/2022 | - |
Comptroller/Controller/Auditor | 24/04/2020 | 14/02/2022 | |
Corporate Officer/Principal | 01/01/2018 | 24/02/2020 |
Historial de carrera de Christopher Sullivan
Antiguos cargos conocidos de Christopher Sullivan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2017 | 01/04/2018 |
OPGEN, INC. | Comptroller/Controller/Auditor | 01/11/2015 | 01/08/2017 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formación de Christopher Sullivan.
University of Maryland | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Comptroller/Controller/Auditor | 3 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sectorial
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
OPGEN, INC. | Commercial Services |
Empresas privadas | 2 |
---|---|
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Christopher Sullivan
- Experiencia